Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial
Research output: Contribution to journal › Journal article › Research › peer-review
RTS,S/AS01E is the lead candidate malaria vaccine. We recently showed efficacy against clinical falciparum malaria in 5-17 month old children, during an average of 8 months follow-up. We aimed to assess the efficacy of RTS,S/AS01E during 15 months of follow-up.
| Original language | English |
|---|---|
| Journal | Lancet Infectious Diseases |
| Volume | 11 |
| Issue number | 2 |
| Pages (from-to) | 102-9 |
| Number of pages | 8 |
| ISSN | 1473-3099 |
| DOIs | |
| Publication status | Published - 2011 |
ID: 32646284